Stocks and Investing
Stocks and Investing
Tue, May 2, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Greg Harrison Maintained (TVTX) at Strong Buy with Decreased Target to $39 on, May 2nd, 2023
Greg Harrison of B of A Securities, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $52 to $39 on, May 2nd, 2023.
Greg has made no other calls on TVTX in the last 4 months.
There are 4 other peers that have a rating on TVTX. Out of the 4 peers that are also analyzing TVTX, 0 agree with Greg's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Greg
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $29 on, Monday, April 17th, 2023
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, February 28th, 2023
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
- Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023
Contributing Sources